Precautions When Co-Administering Levetiracetam and NSAIDs

Key Considerations for Co-Administration

The American Academy of Family Physicians recommends monitoring renal function closely when co-administering levetiracetam and NSAIDs, especially in patients with pre-existing renal disease, advanced age, or those taking other nephrotoxic medications 1, 2
NSAIDs can cause volume-dependent renal failure, interstitial nephritis, and nephrotic syndrome due to their effects on renal prostaglandins produced by COX-2 2
Approximately 2% of patients discontinue NSAIDs due to renal complications 1
The American Academy of Family Physicians suggests using NSAIDs with caution when combining with other medications that potentially decrease renal function 1
Monitoring renal function after initiation of NSAIDs in high-risk patients, including obtaining baseline serum creatinine levels, is recommended 2

The American Heart Association recommends avoiding NSAIDs in patients with congestive heart failure and using them with caution in those with hypertension 1
NSAIDs can increase blood pressure by an average of 5 mm Hg and may worsen heart failure 1, 2
Monitoring blood pressure when starting NSAIDs in patients on antihypertensive medications is advised 2

The American College of Gastroenterology recommends considering GI prophylaxis with a proton pump inhibitor (PPI) or H2 blocker when prescribing NSAIDs, especially in high-risk patients 1, 3
The prevalence of dyspepsia and GI discomfort with NSAIDs is 10-20% 1
The risk of GI bleeding is age-dependent: 1 in 2,100 for adults younger than 45 years and 1 in 110 for adults older than 75 years 1

The American Academy of Family Physicians suggests that NSAIDs have antiplatelet effects and should be avoided in patients with platelet defects or thrombocytopenia 4
When NSAIDs are combined with anticoagulants, there is a 3-6 fold increased risk of GI bleeding 1, 4

The American Academy of Allergy, Asthma, and Immunology recommends using NSAIDs with caution in patients with asthma, especially those with nasal polyps or recurrent sinusitis 1
The prevalence of aspirin-exacerbated respiratory disease is 0.07% in the general population and up to 21% in adults with asthma 1

The National Comprehensive Cancer Network recommends considering topical NSAIDs instead of oral formulations in patients at high risk for adverse effects 3